HIGHLIGHTS
SUMMARY
Type I endometrioid tumors are the most common tumors and 80% of the tumor belongs to this type. The authors propose to study the immunohistochemical expression of BCL-2 in endometrial carcinoma reported from the institute and its correlation with hormone_receptor status and transforming growth factor. In the study group, 44 out of 59 cases (74.57%) were progesterone receptor-positive. Of 9 (85.71%) grade I tumors which is similar to the literature. Out of 33 ER-positive cases, 25 cases (55%) show BCL-2 expression which was higher than the ER-negative . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.